Release Date: 01/10/14 09:31 Summary: Change in substantial holding from MTE Price Sensitive: No Download Document 198.93KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%